Press Releases

Cure Alzheimer’s Fund Receives 100 Percent Rating from Charity Navigator

Organization achieves 4-star rating for 5th consecutive time

(Wellesley, MA) – June 2016 – Cure Alzheimer’s Fund is announcing that Charity Navigator has assigned the organization a score of 100 percent regarding its overall financial health. The nation's largest and most-utilized evaluator of charities, Charity Navigator assigned this score by evaluating two areas of the Fund’s performance – financial health and accountability/transparency – through the IRS Form 990.

Cure Alzheimer’s Fund Partnering with Maria Shriver and Equinox Sports Clubs for MOVE FOR MINDS Experience on May 21st

Cure Alzheimer’s Fund will partner with Maria Shriver and Equinox Sports Clubs for the MOVE FOR MINDS Experience on May 21st. 100 percent of the donations generated from this experience will go to partner organizations of The Women's Alzheimer's Challenge, of which Cure Alzheimer’s Fund is a part.

Increasing Public Understanding of Alzheimer’s in Stuart, Florida

Increasing public understanding of Alzheimer’s disease is the goal of two free screenings of “The Genius of Marian” (right), featured at the 2013 Tribeca Film Festival, and a presentation by leading Alzheimer’s researcher and chair of the Cure Alzheimer’s Fund Research Consortium, Rudy Tanzi, Ph.D. Both events are co-sponsored through Cure Alzheimer’s

Stem Cell Model of Familial Alzheimer's Identifies New AD Genes

A stem cell model of familial Alzheimer’s disease (FAD) was successfully generated in a recent study, allowing researchers to identify 14 genes potentially implicated in the disease. One gene in particular demonstrates the important role inflammation may play in the brain of Alzheimer’s patients. The study was completed by scientists at The New York Stem Cell Foundation (NYSCF) Research Institute in collaboration with scientists at the Icahn School of Medicine at Mount Sinai (ISMMS) and funded in part by the Cure Alzheimer’s Fund (CAF).

Living Brain Cells Created from Biobanked Alzheimer's Brain Tissue

Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute, working in collaboration with scientists from Columbia University Medical Center (CUMC), for the first time generated induced pluripotent stem (iPS) cells lines from non-cryoprotected brain tissue of patients with Alzheimer’s disease.

Drs. Schadt and Huganir Join Research Consortium

Adding to its impressive roster of many of the nation’s leading scientists, the Cure Alzheimer’s Fund Research Consortium is pleased to announce its two newest members, Eric Schadt, Ph.D. (left), and Rick Huganir, Ph.D. (right).

The Research Consortium develops and updates a “roadmap for research” for the most effective and efficient route to slowing, stopping and/or reversing Alzheimer’s disease, the most common form of dementia. Members research their own projects and recruit others whose work will hasten the development of effective therapies.

Stem Cells Accelerate Research & Drug Discovery

Washington—Uncovering the cure for Alzheimer’s disease at a rate never before possible and giving individuals a way to better understand their chances of facing Alzheimer’s are the outcomes of new advances in stem cell research from the Cure Alzheimer’s Fund (CAF) Stem Cell Research Consortium that use skin samples to identify potential therapies for the disease.

Cure Alzheimer’s Fund Receives Highest Rating from Charity Navigator

Cure Alzheimer’s Fund has been awarded the highest rating for sound fiscal management and commitment to accountability and transparency by Charity Navigator, the country’s largest and most-utilized independent evaluator of charities.